NEW YORK (GenomeWeb News) – The Beijing Genomics Institute has purchased 12 new Genome Analyzers for use in its Hong Kong and Shenzhen research centers, the company said today.

BGI will use the new sequencing capacity to support its ongoing and planned programs, including the 1000 Genomes Project, the Chinese Cancer Genome project, the Tree of Life Project, and other agriculture, biomedical, and biofuel research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.